These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1086742)

  • 1. A streptomycin-sensitive revertant of a streptomycin-dependent strain of Vibrio cholerae.
    Sinha VB; Bhattacharjee JW
    Bull World Health Organ; 1976; 53(4):482-4. PubMed ID: 1086742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variability of Vibrio cholerae as affected by subbacteriostatic concentrations of antibiotics].
    Andrusenko IT; Ved'mina EA; Givental' NI; Pasternak NA; Aleksandrova IK
    Antibiotiki; 1984 Oct; 29(10):770-5. PubMed ID: 6508252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on streptomycin dependent mutants of Vibrio cholerae.
    Bhattacharjee JW; Sinha VB
    Indian J Med Res; 1977 Jan; 65(1):29-34. PubMed ID: 863486
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems.
    Bina JE; Provenzano D; Wang C; Bina XR; Mekalanos JJ
    Arch Microbiol; 2006 Sep; 186(3):171-81. PubMed ID: 16804679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typing and antibiotic susceptibility patterns of Vibrio cholerae during six consecutive cholera seasons in north India.
    Kaur H; Lal M
    Trop Gastroenterol; 1998; 19(2):59-61. PubMed ID: 9752752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
    Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
    Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of media with antibiotics for isolating resistant forms of the cholera vibrios].
    Libinzon AE; Bogdanova MI; Gol'dberg AM
    Antibiotiki; 1976 Feb; 21(2):141-4. PubMed ID: 776072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of enterotoxigenic Vibrio cholerae non-01 from the Buriganga river and two ponds of Dhaka, Bangladesh.
    Rahim Z; Aziz KM
    J Diarrhoeal Dis Res; 1992 Dec; 10(4):227-30. PubMed ID: 1296941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of attenuated mutants of Pasteurella multocida strain, pathogenic to calves, in experimental mouse model studies. 4. Immunogenicity of selected revertants of temperature-sensitive, streptomycin-dependent mutants as potential vaccine strains].
    Linde K
    Arch Exp Veterinarmed; 1978; 32(6):943-9. PubMed ID: 749742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 53 kDa protein of Vibrio cholerae classical strain 0395 involved in intestinal colonization.
    Singh SN; Srivastava R; Sinha VB; Srivastava BS
    Microb Pathog; 1994 Aug; 17(2):69-78. PubMed ID: 7861958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The composition of a population of cloned cultures of revertant Vibrio cholerae L forms].
    Danilkina EB; Lomov IuM; Kolesnikov NN; Lobanov VV; Vlasov VP; Cherkasova LR; Badalova IM
    Mikrobiol Zh (1978); 1990; 52(3):10-6. PubMed ID: 2215283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characterization of Vibrio cholerae isolated in Kenya in 1983.
    Ichinose Y; Ehara M; Watanabe S; Shimodori S; Waiyaki PG; Kibue AM; Sang FC; Ngugi J; Kaviti JN
    J Trop Med Hyg; 1986 Oct; 89(5):269-76. PubMed ID: 3795327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence of wild-type and mutant strains of Vibrio cholerae to normal and immune intestinal tissue.
    Bhattacharjee JW; Srivastava BS
    Bull World Health Organ; 1979; 57(1):123-8. PubMed ID: 311709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Streptomycin-dependent mutants of a Pasteurella multocida strain isolated from poultry].
    Karaivanov L; Koleva P; Iurukov M
    Vet Med Nauki; 1981; 18(6):20-6. PubMed ID: 7331223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization.
    Sinha VB; Srivastava BS
    Bull World Health Organ; 1979; 57(4):643-7. PubMed ID: 316741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of the prevalence of regulatory genes controlling virulence gene expression among Vibrio choleraeeltor biovariant strains varying in their pandemic potential].
    Smirnova NI; Nefedov KS; Osin AV; Livanova LF; Krasnov IaM
    Mol Gen Mikrobiol Virusol; 2007; (1):15-22. PubMed ID: 17354604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Vibrio cholerae mutants with the intestinal mucosa of infant mice.
    Guentzel MN; Amerine D; Guerrero D; Gay TV
    Scan Electron Microsc; 1981; 4():115-24. PubMed ID: 7347415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on streptomycin inhibitors with the aid of a streptomycin-dependent Vibrio comma.
    OLITZKI AL; GODINGER D
    J Gen Microbiol; 1959 Feb; 20(1):54-60. PubMed ID: 13631182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.